Publications by authors named "Eric Quemeneur"

Claim this Profile
O
Organoids, organs-on-chips, complex in vitro model: Definitions, applications, validation, ethics.
Guillaume Mottet, Alexandre Grassart, Philippe Barthélemy, Corinne Antignac, Samuel Arrabal

Therapie· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Guillaume Mottet, Alexandre Grassart, Philippe Barthélemy, Corinne Antignac, Samuel Arrabal

Therapie· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment.
Fadi Azar, Jules Deforges, Christelle Demeusoit, Patricia Kleinpeter, Christelle Remy

J Immunother Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D bioprinted CRC model brings to light the replication necessity of an oncolytic vaccinia virus encoding gene to exert an efficient anti-tumoral activity.
Christophe A Marquette, Emma Petiot, Anita Spindler, Caroline Ebel, Mael Nzepa, Eric Quemeneur

Front Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived tumoroids and proteomic signatures: tools for early drug discovery.
Hélène Lê, Jules Deforges, Pasquale Cutolo, Anissa Lamarque, Guoqiang Hua

Front Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12.
Cheyne Kurokawa, Sonia Agrawal, Abhisek Mitra, Elena Galvani, Shannon Burke, Eric Quemeneur

Mol Ther Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and selection of anti-PD-L1 single-domain antibody and tumor necrosis factor superfamily ligands for an optimal vectorization in an oncolytic virus.
Christelle Remy, Elodie Pintado, Marshall Dunlop, Shirley Schön, Patricia Kleinpeter

Front Bioeng Biotechnol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
vascularized immunocompetent patient-derived model to test cancer therapies.
Hélène Lê, Jules Deforges, Guoqiang Hua, Ysia Idoux-Gillet, Charlotte Ponté

iScience· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors.
Jérémy Béguin, Eve Laloy, Sandrine Cochin, Murielle Gantzer, Isabelle Farine

Mol Ther Oncolytics· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
World's First Long-Term Colorectal Cancer Model by 3D Bioprinting as a Mechanism for Screening Oncolytic Viruses.
Colin McGuckin, Nico Forraz, Clément Milet, Mathieu Lacroix, Yordan Sbirkov

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Derived Tumoroid for the Prediction of Radiotherapy and Chemotherapy Responses in Non-Small-Cell Lung Cancer.
Anasse Nounsi, Joseph Seitlinger, Charlotte Ponté, Julien Demiselle, Ysia Idoux-Gillet, Eric Quemeneur

Biomedicines· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct imaging and automatic analysis in tumor-on-chip reveal cooperative antitumoral activity of immune cells and oncolytic vaccinia virus.
Arianna Mencattini, Christine Lansche, Irina Veith, Philippe Erbs, Jean-Marc Balloul, Eric Quemeneur

Biosens Bioelectron· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Derived Lung Tumoroids-An Emerging Technology in Drug Development and Precision Medicine.
Hélène Lê, Joseph Seitlinger, Véronique Lindner, Anne Olland, Pierre-Emmanuel Falcoz

Biomedicines· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination.
Rodrigo Nalio Ramos, Caroline Tosch, Fiorella Kotsias, Marie-Christine Claudepierre, Doris Schmitt, Eric Quemeneur

Clin Transl Immunology· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascularization of Patient-Derived Tumoroid from Non-Small-Cell Lung Cancer and Its Microenvironment.
Joseph Seitlinger, Anasse Nounsi, Ysia Idoux-Gillet, Eloy Santos Pujol, Hélène Lê, Eric Quemeneur

Biomedicines· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8 T cell immunity to reject 'cold' tumors.
Monika Semmrich, Jean-Baptiste Marchand, Laetitia Fend, Matilda Rehn, Christelle Remy

J Immunother Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Pierre Antony, Sylvie Fournel, Joffrey Zoll, Jean-Marie Mantz, Katia Befort

Biol Aujourdhui· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and tolerance of repeated oral administration of 5-fluorocytosine in healthy dogs.
Jérémy Béguin, Matthias Kohlhauer, Eve Laloy, Frédérique Degorce, Baptiste Moreau

BMC Vet Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs.
Jérémy Béguin, Murielle Gantzer, Isabelle Farine, Johann Foloppe, Bernard Klonjkowski

Sci Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs.
Jérémy Béguin, Virginie Nourtier, Murielle Gantzer, Sandrine Cochin, Johann Foloppe, Eric Quemeneur

BMC Vet Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
Patricia Kleinpeter, Christelle Remy-Ziller, Eline Winter, Murielle Gantzer, Virginie Nourtier, Eric Quemeneur

J Virol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic properties of non-vaccinia poxviruses.
Marine Ricordel, Johann Foloppe, Christelle Pichon, Annie Findeli, Caroline Tosch

Oncotarget· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency.
Marine Ricordel, Johann Foloppe, Delphine Antoine, Annie Findeli, Juliette Kempf, Eric Quemeneur

Cancers (Basel)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis